Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 883 All time
- Disclosed funding
- $34.2B 796 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| O OrebellaCompany profile Makes alcohol-free bi-phase skin parfums using botanical and essential oil ingredients sold through Ulta Beauty and global specialty retail Makes alcohol-free bi-phase skin parfums using botanical and essential oil ingredients sold through Ulta Beauty and global specialty retail | Undisclosed | Series A | Consumer | United States | Investors | |
| CL Develops single-molecule PCR technology for genomics measurement | $26M | Series A | Biotech | United States | Investors | |
| S SarisCompany profile Agentic workflow platform for banks and credit unions automating lending, compliance, and back-office operations Agentic workflow platform for banks and credit unions automating lending, compliance, and back-office operations | $28.8M | Series A | Fintech | United States | Investors | |
| S AI-native marketing agency accelerating pharma commercialization | $21M | Series A | Healthtech | United States | Investors | |
| O Builds agentic decisioning layer for CTV advertising | $10M | Series A | Enterprise software | France | Investors | |
| EL Ember LifeSciencesCompany profile Reusable temperature-controlled shipping platform for pharmaceutical cold chain distribution Reusable temperature-controlled shipping platform for pharmaceutical cold chain distribution | $27M | Series A | Healthtech | United States | Investors | |
| ST Secretome TherapeuticsCompany profile Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy | $30M | Series A | Biotech | United States | Investors | |
| R RevEng.AICompany profile Provides binary-level AI analysis of compiled software to detect hidden vulnerabilities and supply chain threats Provides binary-level AI analysis of compiled software to detect hidden vulnerabilities and supply chain threats | $15M | Series A | Cybersecurity | United Kingdom | Investors | |
| PB Pacifico BiolabsCompany profile Produces mycelium-based meat alternatives using existing brewery fermentation infrastructure Produces mycelium-based meat alternatives using existing brewery fermentation infrastructure | €7M | Series A | Foodtech | Germany | Investors | |
| CS C2i SemiconductorsCompany profile Develops software-defined voltage regulator platforms for AI and HPC data center power delivery Develops software-defined voltage regulator platforms for AI and HPC data center power delivery | Undisclosed | Series A | Hardware | India | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Clueso, Santé, Flai
52rounds0led - 2Andreessen Horowitz (a16z)
Eka Robotics, TypeSafe AI, Sharp Performance
29rounds9led - 3General Catalyst
Baba, Melius, Disha (formerly Curelink)
24rounds1led - 4Lightspeed
Warp Sciences, Zenzap, Avarra
21rounds4led - 5Alumni Ventures
Chariot Claims, RegCell, Inc., Lightfield
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.